Ultimovacs ASA (ULTI.OL)
NOK 2.76
(14.79%)
NOK 2.76
(14.79%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -262.84 Million NOK | 37.39% |
| 2022 | -419.82 Million NOK | 26.61% |
| 2021 | -572.08 Million NOK | -30.87% |
| 2020 | -437.14 Million NOK | -10.39% |
| 2019 | -395.98 Million NOK | -242.72% |
| 2018 | -115.54 Million NOK | 31.96% |
| 2017 | -169.8 Million NOK | -132.6% |
| 2016 | -73 Million NOK | -136.78% |
| 2015 | -30.83 Million NOK | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -167.39 Million NOK | 22.64% |
| 2024 Q1 | -216.38 Million NOK | 17.68% |
| 2023 Q3 | -296.1 Million NOK | 12.78% |
| 2023 FY | -262.84 Million NOK | 37.39% |
| 2023 Q2 | -339.48 Million NOK | 15.23% |
| 2023 Q4 | -262.84 Million NOK | 11.23% |
| 2023 Q1 | -400.47 Million NOK | 4.61% |
| 2022 Q3 | -467.26 Million NOK | 3.56% |
| 2022 Q2 | -484.51 Million NOK | 7.18% |
| 2022 FY | -419.82 Million NOK | 26.61% |
| 2022 Q1 | -521.96 Million NOK | 8.76% |
| 2022 Q4 | -419.82 Million NOK | 10.15% |
| 2021 Q2 | -378.91 Million NOK | 6.66% |
| 2021 FY | -572.08 Million NOK | -30.87% |
| 2021 Q1 | -405.94 Million NOK | 7.14% |
| 2021 Q4 | -572.08 Million NOK | -65.67% |
| 2021 Q3 | -345.32 Million NOK | 8.86% |
| 2020 Q4 | -437.14 Million NOK | 2.81% |
| 2020 Q3 | -449.76 Million NOK | 6.23% |
| 2020 Q2 | -479.65 Million NOK | -31.85% |
| 2020 FY | -437.14 Million NOK | -10.39% |
| 2020 Q1 | -363.78 Million NOK | 8.13% |
| 2019 Q2 | -442.37 Million NOK | 0.0% |
| 2019 Q4 | -395.98 Million NOK | 3.09% |
| 2019 FY | -395.98 Million NOK | -242.72% |
| 2019 Q3 | -408.59 Million NOK | 7.64% |
| 2018 Q3 | -123.73 Million NOK | 14.16% |
| 2018 Q1 | -157.76 Million NOK | 7.1% |
| 2018 FY | -115.54 Million NOK | 31.96% |
| 2018 Q2 | -144.14 Million NOK | 8.63% |
| 2018 Q4 | -115.54 Million NOK | 6.62% |
| 2017 FY | -169.8 Million NOK | -132.6% |
| 2017 Q4 | -169.8 Million NOK | 0.0% |
| 2016 FY | -73 Million NOK | -136.78% |
| 2015 FY | -30.83 Million NOK | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Arctic Bioscience AS | -77.55 Million NOK | -238.923% |
| Aqua Bio Technology ASA | -5.82 Million NOK | -4409.457% |
| ArcticZymes Technologies ASA | -237.27 Million NOK | -10.778% |
| BerGenBio ASA | -155.55 Million NOK | -68.977% |
| Hofseth BioCare ASA | 112.89 Million NOK | 332.815% |
| PCI Biotech Holding ASA | -40.86 Million NOK | -543.221% |
| Thor Medical ASA | -41.28 Million NOK | -536.678% |